EGF and myeloid sarcoma: Furthermore, exogenous FGF down-regulates GS activity (125), and so a possible simultaneous presence of excess FGF and EGF deficiency in MS patients may simultaneously further decrease this activity, thus impairing glutamate homeostasis and consequently worsening NEU degeneration and causing ODC demise (see also below).